Karen Joy Shaw - Concepedia

Author

Karen Joy Shaw

Arcturus Therapeutics (United States)ORCID

Also Known As

K J Shaw, K Shaw, K. J. SHAW, K. J. Shaw, K. Shaw, K.J. Shaw, KAREN JOY SHAW, Karen J Shaw, Karen J. Shaw, Karen Joy Shaw

157

Publications

8.3K

Citations

H-Index

103

Concepts

All Affiliations

Arcturus Therapeutics (United States)Amplyx Pharmaceuticals (United States)Academy of Management Johnson & Johnson (United States)University of California, Los Angeles

About

Karen Joy Shaw is an author at Arcturus Therapeutics (United States) specializing in medicine, drug resistance, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	52	3K
2	Health Sciences	16	17	1.3K
3	Natural Sciences	13	13	714
4	Engineering	8	8	371
5	Public Health	2	2	170

Karen Joy Shaw

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes Mark C. Sulavik, Chad Houseweart, Christina Cramer, Antimicrobial Agents and Chemotherapy	2001	495
The Most Frequent Aminoglycoside Resistance Mechanisms--Changes with Time and Geographic Area: A Reflection of Aminoglycoside Usage Patterns? George H. Miller, F. Sabatelli, R S Hare, Clinical Infectious Diseases Klebsiella PneumoniaeGlycobiologyAntibiotic ResistanceAminoglycoside UsageDrug Resistance	1997	234
Novel Ribosomal Mutations in <i>Staphylococcus aureus</i> Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700) Jeffrey B. Locke, M.T. Hilgers, Karen Joy Shaw Antimicrobial Agents and Chemotherapy	2009	202
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains Karen Joy Shaw, Susan M. Poppe, Ronda D. Schaadt, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyVitro SensitivityAntibiotic ResistanceDrug ResistanceMedicinal Chemistry	2008	179
Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform Kenji Kozuka, Ying He, Samantha Koo-McCoy, Stem Cell Reports	2017	168
Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for Transplantation Lisa Saiman, Farah Mehar, Wei-Wei Niu, Clinical Infectious Diseases	1996	166
Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant <i>Staphylococcus aureus</i> Strains Possessing the <i>cfr</i> Methyltransferase Gene or Ribosomal Mutations Jeffrey B. Locke, John M. Finn, M.T. Hilgers, Antimicrobial Agents and Chemotherapy	2010	145
Comparison of the Changes in Global Gene Expression of <i>Escherichia coli</i> Induced by Four Bactericidal Agents Karen Joy Shaw, Nancy Miller, Xuejun Liu, Microbial Physiology	2003	136
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris Christopher Hager, Emily L. Larkin, Lisa Long, Antimicrobial Agents and Chemotherapy	2018	134
Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin Jeffrey B. Locke, M.T. Hilgers, Karen Joy Shaw Antimicrobial Agents and Chemotherapy Oxazolidinone ResistanceAntibiotic AdjuvantGeneticsStaphylococcus AureusMolecular Biology	2009	133

Page 1